...
首页> 外文期刊>Trends in Ecology & Evolution >Design, synthesis, andin vitroevaluation of aza-peptide aldehydes and ketones as novel and selective protease inhibitors
【24h】

Design, synthesis, andin vitroevaluation of aza-peptide aldehydes and ketones as novel and selective protease inhibitors

机译:AZA肽醛和酮的设计,合成,亚硫代维大致新型和选择性蛋白酶抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Aza-peptide aldehydes and ketones are a new class of reversible protease inhibitors that are specific for the proteasome and clan CD cysteine proteases. We designed and synthesised aza-Leu derivatives that were specific for the chymotrypsin-like active site of the proteasome, aza-Asp derivatives that were effective inhibitors of caspases-3 and -6, and aza-Asn derivatives that inhibitedS. mansoniandI. ricinuslegumains. The crystal structure of caspase-3 in complex with our caspase-specific aza-peptide methyl ketone inhibitor with an aza-Asp residue at P1 revealed a covalent linkage between the inhibitor carbonyl carbon and the active site cysteinyl sulphur. Aza-peptide aldehydes and ketones showed no cross-reactivity towards cathepsin B or chymotrypsin. The initialin vitroselectivity of these inhibitors makes them suitable candidates for further development into therapeutic agents to potentially treat multiple myeloma, neurodegenerative diseases, and parasitic infections.
机译:AZA-肽醛和酮是一种新的可逆蛋白酶抑制剂,其特异于蛋白酶体和氏族CD半胱氨酸蛋白酶。 我们设计和合成的AZA-Leu衍生物,其特异性对蛋白酶体,AZA-ASP衍生物的胰蛋白酶样蛋白样活性位点具有有效抑制剂的抑制剂-3和-6的有效抑制剂和抑制的AZA-ASN衍生物。 Mansoniandi。 蓖麻假瘤。 Caspase-3的晶体结构与我们的胱天蛋白酶特异性AZA-肽甲基酮抑制剂在P1下含有AZA-ASP残基的甲基酮抑制剂揭示了抑制剂羰基碳和活性位点胱天基硫之间的共价键。 AZA-肽醛和酮表明对组织蛋白酶B或胰凝乳蛋白没有交叉反应性。 这些抑制剂的初始荧光蛋白选择性使它们适用于进一步发展到治疗剂中的候选者,以潜在地治疗多发性骨髓瘤,神经变性疾病和寄生感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号